DXCM vs. PODD: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at DXCM and PODD, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Overview
DXCM’s market capitalization of 32.69 billion USD is substantially larger than PODD’s 20.36 billion USD, indicating a significant difference in their market valuations.
With betas of 1.46 for DXCM and 1.38 for PODD, both stocks show similar sensitivity to overall market movements.
| Symbol | DXCM | PODD |
|---|---|---|
| Company Name | DexCom, Inc. | Insulet Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Devices |
| CEO | Kevin Ronald Sayer | Ashley A. McEvoy |
| Price | 83.37 USD | 289.32 USD |
| Market Cap | 32.69 billion USD | 20.36 billion USD |
| Beta | 1.46 | 1.38 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | April 14, 2005 | May 15, 2007 |
| ADR | No | No |
Historical Performance
This chart compares the performance of DXCM and PODD by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period.
Data is adjusted for dividends and splits.
Profitability
Return on Equity
DXCM
24.38%
Medical - Devices Industry
- Max
- 49.04%
- Q3
- 9.53%
- Median
- -7.46%
- Q1
- -32.83%
- Min
- -82.64%
In the upper quartile for the Medical - Devices industry, DXCM’s Return on Equity of 24.38% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
PODD
34.53%
Medical - Devices Industry
- Max
- 49.04%
- Q3
- 9.53%
- Median
- -7.46%
- Q1
- -32.83%
- Min
- -82.64%
In the upper quartile for the Medical - Devices industry, PODD’s Return on Equity of 34.53% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Return on Invested Capital
DXCM
9.42%
Medical - Devices Industry
- Max
- 21.88%
- Q3
- 6.63%
- Median
- -1.11%
- Q1
- -21.08%
- Min
- -51.95%
In the upper quartile for the Medical - Devices industry, DXCM’s Return on Invested Capital of 9.42% signifies a highly effective use of its capital to generate profits when compared to its peers.
PODD
15.17%
Medical - Devices Industry
- Max
- 21.88%
- Q3
- 6.63%
- Median
- -1.11%
- Q1
- -21.08%
- Min
- -51.95%
In the upper quartile for the Medical - Devices industry, PODD’s Return on Invested Capital of 15.17% signifies a highly effective use of its capital to generate profits when compared to its peers.
Net Profit Margin
DXCM
12.90%
Medical - Devices Industry
- Max
- 44.80%
- Q3
- 9.77%
- Median
- -5.53%
- Q1
- -29.37%
- Min
- -87.68%
A Net Profit Margin of 12.90% places DXCM in the upper quartile for the Medical - Devices industry, signifying strong profitability and more effective cost management than most of its peers.
PODD
18.29%
Medical - Devices Industry
- Max
- 44.80%
- Q3
- 9.77%
- Median
- -5.53%
- Q1
- -29.37%
- Min
- -87.68%
A Net Profit Margin of 18.29% places PODD in the upper quartile for the Medical - Devices industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin
DXCM
15.25%
Medical - Devices Industry
- Max
- 30.13%
- Q3
- 13.12%
- Median
- 3.47%
- Q1
- -24.42%
- Min
- -80.56%
An Operating Profit Margin of 15.25% places DXCM in the upper quartile for the Medical - Devices industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
PODD
15.50%
Medical - Devices Industry
- Max
- 30.13%
- Q3
- 13.12%
- Median
- 3.47%
- Q1
- -24.42%
- Min
- -80.56%
An Operating Profit Margin of 15.50% places PODD in the upper quartile for the Medical - Devices industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | DXCM | PODD |
|---|---|---|
| Return on Equity (TTM) | 24.38% | 34.53% |
| Return on Assets (TTM) | 7.93% | 11.43% |
| Return on Invested Capital (TTM) | 9.42% | 15.17% |
| Net Profit Margin (TTM) | 12.90% | 18.29% |
| Operating Profit Margin (TTM) | 15.25% | 15.50% |
| Gross Profit Margin (TTM) | 59.39% | 70.39% |
Financial Strength
Current Ratio
DXCM
1.50
Medical - Devices Industry
- Max
- 12.68
- Q3
- 6.30
- Median
- 4.05
- Q1
- 1.85
- Min
- 0.01
DXCM’s Current Ratio of 1.50 falls into the lower quartile for the Medical - Devices industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
PODD
4.47
Medical - Devices Industry
- Max
- 12.68
- Q3
- 6.30
- Median
- 4.05
- Q1
- 1.85
- Min
- 0.01
PODD’s Current Ratio of 4.47 aligns with the median group of the Medical - Devices industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio
DXCM
1.14
Medical - Devices Industry
- Max
- 2.34
- Q3
- 1.09
- Median
- 0.37
- Q1
- 0.08
- Min
- 0.00
DXCM’s leverage is in the upper quartile of the Medical - Devices industry, with a Debt-to-Equity Ratio of 1.14. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
PODD
0.06
Medical - Devices Industry
- Max
- 2.34
- Q3
- 1.09
- Median
- 0.37
- Q1
- 0.08
- Min
- 0.00
Falling into the lower quartile for the Medical - Devices industry, PODD’s Debt-to-Equity Ratio of 0.06 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio
DXCM
43.93
Medical - Devices Industry
- Max
- 18.18
- Q3
- 7.53
- Median
- 0.85
- Q1
- -9.80
- Min
- -33.94
With an Interest Coverage Ratio of 43.93, DXCM demonstrates a superior capacity to service its debt, placing it well above the typical range for the Medical - Devices industry. This stems from either robust earnings or a conservative debt load.
PODD
8.27
Medical - Devices Industry
- Max
- 18.18
- Q3
- 7.53
- Median
- 0.85
- Q1
- -9.80
- Min
- -33.94
PODD’s Interest Coverage Ratio of 8.27 is in the upper quartile for the Medical - Devices industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
Financial Strength at a Glance
| Symbol | DXCM | PODD |
|---|---|---|
| Current Ratio (TTM) | 1.50 | 4.47 |
| Quick Ratio (TTM) | 1.32 | 3.63 |
| Debt-to-Equity Ratio (TTM) | 1.14 | 0.06 |
| Debt-to-Asset Ratio (TTM) | 0.38 | 0.02 |
| Net Debt-to-EBITDA Ratio (TTM) | 1.89 | -2.87 |
| Interest Coverage Ratio (TTM) | 43.93 | 8.27 |
Growth
The following charts compare key year-over-year (YoY) growth metrics for DXCM and PODD. These metrics are based on the companies’ annual financial reports.
Revenue Growth
Earnings Per Share (EPS) Growth
Free Cash Flow Growth
Dividend
Dividend Yield
DXCM
0.00%
Medical - Devices Industry
- Max
- 3.57%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
PODD
0.00%
Medical - Devices Industry
- Max
- 3.57%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio
DXCM
0.00%
Medical - Devices Industry
- Max
- 102.12%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
PODD
0.00%
Medical - Devices Industry
- Max
- 102.12%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | DXCM | PODD |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
Price-to-Earnings Ratio
DXCM
60.92
Medical - Devices Industry
- Max
- 90.56
- Q3
- 56.92
- Median
- 43.19
- Q1
- 21.79
- Min
- 5.55
A P/E Ratio of 60.92 places DXCM in the upper quartile for the Medical - Devices industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.
PODD
50.55
Medical - Devices Industry
- Max
- 90.56
- Q3
- 56.92
- Median
- 43.19
- Q1
- 21.79
- Min
- 5.55
PODD’s P/E Ratio of 50.55 is within the middle range for the Medical - Devices industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Forward P/E to Growth Ratio
DXCM
2.79
Medical - Devices Industry
- Max
- 6.56
- Q3
- 3.52
- Median
- 2.22
- Q1
- 0.55
- Min
- 0.03
DXCM’s Forward PEG Ratio of 2.79 is within the middle range of its peers in the Medical - Devices industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.
PODD
2.38
Medical - Devices Industry
- Max
- 6.56
- Q3
- 3.52
- Median
- 2.22
- Q1
- 0.55
- Min
- 0.03
PODD’s Forward PEG Ratio of 2.38 is within the middle range of its peers in the Medical - Devices industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.
Price-to-Sales Ratio
DXCM
7.88
Medical - Devices Industry
- Max
- 15.74
- Q3
- 8.12
- Median
- 3.40
- Q1
- 2.37
- Min
- 0.42
DXCM’s P/S Ratio of 7.88 aligns with the market consensus for the Medical - Devices industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
PODD
9.26
Medical - Devices Industry
- Max
- 15.74
- Q3
- 8.12
- Median
- 3.40
- Q1
- 2.37
- Min
- 0.42
PODD’s P/S Ratio of 9.26 is in the upper echelon for the Medical - Devices industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio
DXCM
14.39
Medical - Devices Industry
- Max
- 16.65
- Q3
- 8.03
- Median
- 3.73
- Q1
- 1.92
- Min
- 0.65
DXCM’s P/B Ratio of 14.39 is in the upper tier for the Medical - Devices industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
PODD
15.28
Medical - Devices Industry
- Max
- 16.65
- Q3
- 8.03
- Median
- 3.73
- Q1
- 1.92
- Min
- 0.65
PODD’s P/B Ratio of 15.28 is in the upper tier for the Medical - Devices industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
| Symbol | DXCM | PODD |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 60.92 | 50.55 |
| Forward PEG Ratio (TTM) | 2.79 | 2.38 |
| Price-to-Sales Ratio (P/S, TTM) | 7.88 | 9.26 |
| Price-to-Book Ratio (P/B, TTM) | 14.39 | 15.28 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 56.83 | 69.99 |
| EV-to-EBITDA (TTM) | 38.62 | 45.81 |
| EV-to-Sales (TTM) | 8.29 | 8.71 |